• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC?

作者信息

Brooks Eric D, Verma Vivek, Chang Joe Y

机构信息

Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States.

Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA, United States.

出版信息

Front Oncol. 2019 Jun 21;9:551. doi: 10.3389/fonc.2019.00551. eCollection 2019.

DOI:10.3389/fonc.2019.00551
PMID:31293978
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6598426/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3655/6598426/f50d6a12d789/fonc-09-00551-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3655/6598426/f50d6a12d789/fonc-09-00551-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3655/6598426/f50d6a12d789/fonc-09-00551-g0001.jpg

相似文献

1
Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC?立体定向消融放疗治疗早期非小细胞肺癌后，病理反应等同于临床反应吗？
Front Oncol. 2019 Jun 21;9:551. doi: 10.3389/fonc.2019.00551. eCollection 2019.
2
Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis.立体定向体部放疗或立体定向消融放疗与手术治疗T1-3N0M0期非小细胞肺癌患者的疗效比较：一项系统评价和荟萃分析
Onco Targets Ther. 2017 Jun 7;10:2885-2892. doi: 10.2147/OTT.S138701. eCollection 2017.
3
Improved survival with stereotactic ablative radiotherapy (SABR) over lobectomy for early stage non-small cell lung cancer (NSCLC): addressing the fallout of disruptive randomized data.立体定向消融放疗（SABR）较肺叶切除术治疗早期非小细胞肺癌（NSCLC）可提高生存率：解决突破性随机数据的影响。
Ann Transl Med. 2015 Jul;3(11):149. doi: 10.3978/j.issn.2305-5839.2015.06.15.
4
Cost-effectiveness analysis of stereotactic body radiotherapy and surgery for medically operable early stage non small cell lung cancer.立体定向体部放疗与手术治疗可手术的早期非小细胞肺癌的成本效果分析。
Radiother Oncol. 2018 Sep;128(3):534-540. doi: 10.1016/j.radonc.2018.04.013. Epub 2018 Apr 26.
5
Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC).简短报告：一项测量立体定向消融放疗（SABR）联合手术治疗早期非小细胞肺癌（MISSILE-NSCLC）的II期试验的中期安全性结果。
Radiat Oncol. 2017 Jan 27;12(1):30. doi: 10.1186/s13014-017-0770-7.
6
Surgery or stereotactic ablative radiation therapy: how will be treated operable patients with early stage not small cell lung cancer in the next future?手术还是立体定向消融放疗：在未来，早期非小细胞肺癌的可手术患者将如何治疗？
Ann Transl Med. 2015 Feb;3(2):25. doi: 10.3978/j.issn.2305-5839.2015.01.06.
7
Lobectomy versus stereotactic ablative radiotherapy for medically operable patients with stage IA non-small cell lung cancer: A virtual randomized phase III trial stratified by age.肺叶切除术与立体定向消融放疗治疗可手术的 I 期非小细胞肺癌患者：一项按年龄分层的虚拟随机 III 期试验。
Thorac Cancer. 2019 Jun;10(6):1489-1499. doi: 10.1111/1759-7714.13103. Epub 2019 May 23.
8
Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly.立体定向体部放射治疗（SBRT）治疗老年早期肺癌。
Semin Oncol. 2018 Aug;45(4):210-219. doi: 10.1053/j.seminoncol.2018.06.002. Epub 2018 Jul 1.
9
Forecasting the impact of stereotactic ablative radiotherapy for early-stage lung cancer on the thoracic surgery workforce.预测立体定向消融放疗对早期肺癌患者的影响对胸外科劳动力的影响。 （此译文存在逻辑重复问题，原英文标题核心意思是预测立体定向消融放疗对早期肺癌的影响以及对胸外科人力的影响，更准确译文为：预测立体定向消融放疗对早期肺癌的影响及对胸外科人力的作用 ） 优化后译文：预测立体定向消融放疗对早期肺癌的影响及对胸外科人力的作用 注：原英文标题表述似乎不太准确规范，正常逻辑应该是两方面影响表述更清晰合理，上述是基于英文原意尽量优化后的译文解释，实际单纯翻译按照字面为：预测立体定向消融放疗对早期肺癌的影响对胸外科劳动力的影响 。 严格按要求不添加解释说明的译文为：预测立体定向消融放疗对早期肺癌的影响对胸外科劳动力的影响 。 但此译文逻辑稍显混乱。
Eur J Cardiothorac Surg. 2016 Jun;49(6):1599-606. doi: 10.1093/ejcts/ezv421. Epub 2016 Jan 21.
10
Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults.立体定向放射治疗、肺段切除术和肺叶切除术治疗老年早期非小细胞肺癌的成本效益分析
J Geriatr Oncol. 2015 Jul;6(4):324-31. doi: 10.1016/j.jgo.2015.05.002. Epub 2015 Jun 17.

引用本文的文献

1
Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery.立体定向消融放疗治疗可手术的 I 期非小细胞肺癌（修订后的 STARS）：一项单臂前瞻性试验的长期结果，与手术进行了预设比较。
Lancet Oncol. 2021 Oct;22(10):1448-1457. doi: 10.1016/S1470-2045(21)00401-0. Epub 2021 Sep 13.
2
Salvage Therapy for Locoregional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage NSCLC.立体定向消融放疗后局部区域复发的挽救性治疗：早期非小细胞肺癌。
J Thorac Oncol. 2020 Feb;15(2):176-189. doi: 10.1016/j.jtho.2019.10.016. Epub 2019 Nov 9.

本文引用的文献

1
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.立体定向消融放疗联合手术治疗早期非小细胞肺癌的融合度评估：一项 2 期临床试验。
JAMA Oncol. 2019 May 1;5(5):681-688. doi: 10.1001/jamaoncol.2018.6993.
2
Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location.立体定向体部放疗治疗可手术与不可手术Ⅰ期非小细胞肺癌的 5 年长期疗效：可手术性、分割方案、肿瘤大小和肿瘤部位分析。
Clin Lung Cancer. 2019 Jan;20(1):e63-e71. doi: 10.1016/j.cllc.2018.09.004. Epub 2018 Sep 20.
3
Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial.
立体定向体部放疗治疗可手术的早期肺癌：NRG 肿瘤学 RTOG 0618 试验结果。
JAMA Oncol. 2018 Sep 1;4(9):1263-1266. doi: 10.1001/jamaoncol.2018.1251.
4
Surgical quality of wedge resection affects overall survival in patients with early stage non-small cell lung cancer.楔形切除术的手术质量影响早期非小细胞肺癌患者的总生存率。
J Thorac Cardiovasc Surg. 2018 Jul;156(1):380-391.e2. doi: 10.1016/j.jtcvs.2018.02.095. Epub 2018 Mar 13.
5
Time interval between neoadjuvant chemoradiotherapy and surgery for oesophageal or junctional cancer: A nationwide study.新辅助放化疗与食管或食管胃交界癌手术的时间间隔：一项全国性研究。
Eur J Cancer. 2018 Mar;91:76-85. doi: 10.1016/j.ejca.2017.12.009. Epub 2018 Jan 30.
6
7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial.I期非小细胞肺癌患者立体定向消融放疗后的7年随访：一项2期临床试验的结果
Cancer. 2017 Aug 15;123(16):3031-3039. doi: 10.1002/cncr.30693. Epub 2017 Mar 27.
7
Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer.直肠癌放疗方案的随机斯德哥尔摩III期试验中的肿瘤消退情况。
Br J Surg. 2015 Jul;102(8):972-8; discussion 978. doi: 10.1002/bjs.9811.
8
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.立体定向消融放疗与肺叶切除术治疗可手术的Ⅰ期非小细胞肺癌：两项随机试验的汇总分析
Lancet Oncol. 2015 Jun;16(6):630-7. doi: 10.1016/S1470-2045(15)70168-3. Epub 2015 May 13.
9
Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned.立体定向消融放疗治疗中央型早期非小细胞肺癌：我们的经验教训。
J Thorac Oncol. 2015 Apr;10(4):577-85. doi: 10.1097/JTO.0000000000000453.
10
Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer.从新辅助放化疗到手术的时间增加与食管癌更高的病理完全缓解率相关。
Ann Thorac Surg. 2015 Jan;99(1):270-6. doi: 10.1016/j.athoracsur.2014.08.033. Epub 2014 Nov 18.